Cara Therapeutics
Transforming the way pruritus is treated to bring quality to the lives of those who suffer
46 employees · est. 2004 · Stamford, United States
Tricida, Inc.
Tricida is a pharmaceutical company working to turn the tide on metabolic acidosis and progression of CKD.
16 employees · est. 2013 · South San Francisco, United...
Cara Therapeutics is the older company (2004 vs 2013).
Side-by-Side Comparison
| Metric | Cara Therapeutics | Tricida, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2004 older | 2013 |
| Headquarters | ||
| Headquarters | Stamford, United States | South San Francisco, United States |
| Employees | ||
| Employees | 46 | 16 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post Ipo Debt | Post Ipo Debt |
| Total Funding | ||
| Total Funding | $517.20M | $624.01M |
| Funding Rounds | ||
| Funding Rounds | 10 | 9 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Pruritus Treatment, KORSUVA, Difelikefalin, FDA-approved Treatment, Chronic Kidney Disease, Hemodialysis, Oral Formulation, Phase 3 Programs, Non-dialysis Dependent Advanced Chronic Kidney Disease, Atopic Dermatitis, Notalgia Paresthetica, Clinical Trials, Innovation, Medical Research | Pharmaceutical Company, Metabolic Acidosis, Chronic Kidney Disease, Drug Candidate, Polymer-based Treatment, Therapeutics Development, CKD Progression, Seasoned Management Team, Therapeutics Commercialization, Polymer Development, Kidney-related Diseases, Veverimer, TRC101, Non-absorbed Drug, Oral Administration |
| Website | ||
| Website | caratherapeutics.com | tricida.com |
About Cara Therapeutics
Cara Therapeutics, founded in 2004 and headquartered in the United States, is a biopharmaceutical innovator committed to enhancing the treatment of pruritus through novel therapeutic approaches. With its slogan, "Transforming the way pruritus is treated to bring quality to the lives of those who suf...
About Tricida, Inc.
Tricida, Inc. is a pharmaceutical company with a mission to combat metabolic acidosis and the progression of chronic kidney disease (CKD). The company's flagship drug candidate, veverimer (TRC101), is a non-absorbed, orally-administered polymer designed specifically to address metabolic acidosis in...
We will tell you when either one moves
BounceWatch watches Cara Therapeutics and Tricida, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cara Therapeutics and Tricida, Inc. — by email.
Frequently Asked Questions
Compare Cara Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Cara Therapeutics on 12 Sep 2024, and Tricida, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.